Google's AI tuberculosis screening moves from research to clinic
What happened
On 24 October 2026, teams from Google Research and Google for Health shared at IDWeek 2026 the path by which tuberculosis screening AI moved from research into clinical use. According to the report, the work began with a benchmark study published in Radiology in 2019, completed multi-site prospective validation in NEJM AI in 2024, and was then turned by the South African company Nexus AI into a clinical diagnostic tool certified under CE MDR class IIb. The report does not mention specific details of MedGemma's open-source progress.
Written by AI from the reports · updated 2 h ago
Timeline
Follow the reports to see the event from each side.
- Google ResearchBringing foundational models to the front lines of TB screening
Over the past several years, our team across Google Research and Google for Health has worked to change that trajectory: moving from an AI-based tool that builds on our existing work in medical imaging to identify people with presumptive TB for follow-up testing to prospective clinical trials, regulatory clearance with local partners, and ultimately open foundation models like MedGemma that empower public health systems worldwide.
Heat of this event
Not enough continuous observations yet to draw a trend.